Survey of the feline leukemia virus infection status of cats in Southern Germany

Journal of Feline Medicine and Surgery

Volumn 14, Issue 6, 2012, Pages 392-398

  Englert, Theresa ^a   Lutz, Hans ^b   Sauter Louis, Carola ^a   Hartmann, Katrin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FELINE LEUKEMIA VIRUS;

CYCLINE; P27 ANTIGEN; VIRUS ANTIBODY; VIRUS DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE LEUKEMIA VIRUS; GERMANY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; RETROVIRUS INFECTION; SALIVA; VIROLOGY; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CAT DISEASES; CATS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GERMANY; LEUKEMIA VIRUS, FELINE; POLYMERASE CHAIN REACTION; PREVALENCE; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROVIRIDAE INFECTIONS; SALIVA; TUMOR VIRUS INFECTIONS;

EID: 84866017325     PISSN: 1098612X     EISSN: 15322750     Source Type: Journal    
DOI: 10.1177/1098612X12440531     Document Type: Article

References (32)

1. Yilmaz H,Ilgaz A,Harbour DA.Prevalence of FIV and FeLV infections in cats in Istanbul.J Feline Med Surg. 2000;2:69-70.
2. Arjona A,Escolar E,Soto I,Barquero N,Martin D,Gomez-Lucia E.Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects.J Clin Microbiol. 2000;38:3448-3449.
3. Hartmann K,Block A,Ferk G,Beer B,Vollmar A,Lutz H.Treatment of feline leukemia virus (FeLV) infection.Vet Microbiol. 1999;69:111-113.
4. Flynn JN,Dunham SP,Watson V,Jarrett O.Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection.J Virol. 2002;76:2306-2315.
5. Hofmann-Lehmann R,Cattori V,Tandon R,Boretti FS,Meli ML,Riond B, et al.Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up.Vaccine. 2007;25:5531-5539.
6. Hartmann KInfectious diseases of the dog and the cat. 3rd ed.Athens: Saunders Elsevier, 2005, pp 105-130.Greene C, ed. Athens: Saunders Elsevier; 2005:105-130.
7. Louwerens M,London CA,Pedersen NC,Lyons LA.Feline lymphoma in the post-feline leukemia virus era.J Vet Intern Med. 2005;19:329-335.
8. Gleich SE,Krieger S,Hartmann K.Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany.J Feline Med Surg. 2009;11:985-992.
9. Rojko JL,Hoover EA,Quackenbush SL,Olsen RG.Reactivation of latent feline leukaemia virus infection.Nature. 1982;298:385-388.
10. Torres AN,Mathiason CK,Hoover EA.Re-examination of feline leukemia virus: host relationships using real-time PCR.Virology. 2005;332:272-283.
11. Hofmann-Lehmann R,Huder JB,Gruber S,Boretti F,Sigrist B,Lutz H.Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats.J Gen Virol. 2001;82:1589-1596.
12. Major A,Cattori V,Boenzli E,Riond B,Ossent P,Meli ML, et al.Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection.Vet Res. 2009;41:17.
13. Benveniste RE,Sherr CJ,Todaro GJ.Evolution of type C viral genes: origin of feline leukemia virus.Science. 1975;190:886-888.
14. Tandon R,Cattori V,Pepin AC,Riond B,Meli ML,McDonald M, et al.Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats.Virus Res. 2008;135:136-143.
15. Tandon R,Cattori V,Gomes-Keller MA,Meli ML,Golder MC,Lutz H, et al.Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction.J Virol Methods. 2005;130:124-132.
16. Gomes-Keller MA,Tandon R,Gonczi E,Meli ML,Hofmann-Lehmann R,Lutz H.Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats.Vet Microbiol. 2006;112:11-21.
17. Gomes-Keller MA,Gonczi E,Tandon R,Riondato F,Hofmann-Lehmann R,Meli ML, et al.Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods.J Clin Microbiol. 2006;44:916-922.
18. Lutz H,Pedersen NC,Durbin R,Theilen GH.Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27.J Immunol Methods. 1983;56:209-220.
19. Hartmann K,Werner RM,Egberink H,Jarrett O.Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections.Veterinary Record. 2001;149:317-320.
20. Adler K,Radeloff I,Stephan B,Greife H,Hellmann K.Bacteriological and virological status in upper respiratory tract infections of cats (cat common cold complex).Berl Munch Tierarztl Wochenschr. 2007;120:120-125.
21. Bauer N,Balzer HJ,Thure S,Moritz A.Prevalence of feline haemotropic mycoplasmas in convenience samples of cats in Germany.J Feline Med Surg. 2008;10:252-258.
22. Lubkin SR,Romatowski J,Zhu M,Kulesa PM,White KA.Evaluation of feline leukemia virus control measures.J Theor Biol. 1996;178:53-60.
23. Hardy WDThe Retroviridae. Levy JK, ed. New York: Plenum Press; 1993:109-180.
24. Lutz H,Pedersen N,Higgins J,Hubscher U,Troy FA,Theilen GH.Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus.Cancer Res. 1980;40:3642-3651.
25. Hofmann-Lehmann R,Cattori V,Tandon R,Boretti FS,Meli ML,Riond B, et al.How molecular methods change our views of FeLV infection and vaccination.Vet Immunol Immunopathol. 2008;123:119-123.
26. Hanlon L,Argyle D,Bain D,Nicolson L,Dunham S,Golder MC, et al.Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.J Virol. 2001;75:8424-8433.
27. Flynn JN,Hanlon L,Jarrett O.Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes.Immunology. 2000;101:120-125.
28. Brunner C,Kanellos T,Meli ML,Sutton DJ,Gisler R,Gomes-Keller MA, et al.Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component.Vaccine. 2006;24:1838-1846.
29. Langhammer S,Hubner J,Kurth R,Denner J.Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.Immunology. 2006;117:229-237.
30. Sparkes AH.Feline leukaemia virus and vaccination.J Feline Med Surg. 2003;5:97-100.
31. Hofmann-Lehmann R,Tandon R,Boretti FS,Meli ML,Willi B,Cattori V, et al.Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.Vaccine. 2006;24:1087-1094.
32. Jarrett O,Ganiere JP.Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine.Vet Rec. 1996;138:7-11.